, APAC
Photo from Pexels by Cottonbro Studio

Gastrointestinal diseases therapeutics market to grow by $18.5b in 2028

This is due to the rising prevalence of chronic digestive conditions.

The global gastrointestinal disease therapeutics market is estimated to grow by $18.5b from 2024 to 2028, with a compound annual growth rate of 6.81% according to Technavio. 

This is due to the rising prevalence of chronic digestive conditions like gastroesophageal reflux disease (GERD), inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and gastrointestinal cancers.

Market trends include the use of telemedicine, biologics, Proton Pump Inhibitors (PPIs), aminosalicylates, antacids, laxatives, and H2 and H1 antagonists.

However, the high cost of gastrointestinal therapeutics may hinder market growth as the average treatment costs for ulcerative colitis and Crohn’s disease are $6,000 to $12,000 and $30,000 to $32,000, respectively. 

Market growth is expected in North America, Asia, Europe, and the rest of world.

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Exclusives

Saudi’s KFSHRC banks on innovation to transform healthcare
The hospital is accelerating adoption of emerging technologies to position itself as a global leader in medicine
Angkor Hospital eyes trauma centre for children
The facility will have an ICU, emergency room, operating theatre and a surgical ward.